Journal of gastroenterology and hepatology · 2026
Effects of Successful Versus Delayed/Failed Helicobacter pylori Eradication Therapy on Subsequent Fracture Risk: a Population-Based Cohort Study.
СтатьяСравнительное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Tan Jing Tong, Mao Xianhua, Cheung Ching-Lung, Ooi Poh Hwa, Seto Wai-Kay, Leung Wai-K, Cheung Ka-Shing
Аннотация
BACKGROUND: We determined the outcomes of Helicobacter pylori (HP) eradication on fracture risk.
METHODS: This was a retrospective cohort study of patients who had received clarithromycin-based triple therapy for HP infection or undergone upper endoscopy with no HP infection found (HP negative) between 2003 and 2012 in Hong Kong. Patients were divided into three groups: (i) HP-negative, (ii) successful HP eradication, and (iii) delayed/failed HP eradication, and were observed till fracture development, death, or end of study. Propensity score (PS) adjustment was performed to account for ≥ 20 covariates (age, sex, comorbidities, and time-varying medication use). Following the establishment of PS-matched cohorts, the hazard ratio (HR) of fracture with HP eradication outcome was calculated by a multivariable Cox model.
RESULTS: Of 322 180 eligible patients, 250 978 (77.9%) were HP-negative, 61 892 (19.2%) had successful HP eradication, and 9310 (2.9%) delayed/failed eradication. During a median follow-up of 11.5 years (IQR: 8.8-14.2), 16 935 (5.3%) developed fracture (vertebra: 1825; hip: 8338; humerus: 2147; forearm: 4080; carpal/wrist: 545). Compared with the HP-negative group, the successful HP eradication group did not have a higher fracture risk (HR: 1.02; 95% CI: 0.89-1.16). However, a higher fracture risk was observed in the delayed/failed HP eradication group (HR: 1.37; 95% CI: 1.21-1.56). Among delayed/failed HP eradication patients with and without prior history of gastric ulcer, the HR was 2.21 (95% CI: 1.10-4.45) and 1.35 (95% CI: 1.19-1.54), respectively.
CONCLUSION: When compared with HP-negative individuals, only HP-positive patients with delayed/failed HP eradication had a higher fracture risk, particularly in those with a prior history of gastric ulcer. These results may suggest a potential protective association of successful HP eradication and subsequent fracture risk.
METHODS: This was a retrospective cohort study of patients who had received clarithromycin-based triple therapy for HP infection or undergone upper endoscopy with no HP infection found (HP negative) between 2003 and 2012 in Hong Kong. Patients were divided into three groups: (i) HP-negative, (ii) successful HP eradication, and (iii) delayed/failed HP eradication, and were observed till fracture development, death, or end of study. Propensity score (PS) adjustment was performed to account for ≥ 20 covariates (age, sex, comorbidities, and time-varying medication use). Following the establishment of PS-matched cohorts, the hazard ratio (HR) of fracture with HP eradication outcome was calculated by a multivariable Cox model.
RESULTS: Of 322 180 eligible patients, 250 978 (77.9%) were HP-negative, 61 892 (19.2%) had successful HP eradication, and 9310 (2.9%) delayed/failed eradication. During a median follow-up of 11.5 years (IQR: 8.8-14.2), 16 935 (5.3%) developed fracture (vertebra: 1825; hip: 8338; humerus: 2147; forearm: 4080; carpal/wrist: 545). Compared with the HP-negative group, the successful HP eradication group did not have a higher fracture risk (HR: 1.02; 95% CI: 0.89-1.16). However, a higher fracture risk was observed in the delayed/failed HP eradication group (HR: 1.37; 95% CI: 1.21-1.56). Among delayed/failed HP eradication patients with and without prior history of gastric ulcer, the HR was 2.21 (95% CI: 1.10-4.45) and 1.35 (95% CI: 1.19-1.54), respectively.
CONCLUSION: When compared with HP-negative individuals, only HP-positive patients with delayed/failed HP eradication had a higher fracture risk, particularly in those with a prior history of gastric ulcer. These results may suggest a potential protective association of successful HP eradication and subsequent fracture risk.